- Home
- RVSB vs ALVR Comparison
RVSB vs ALVR Comparison
Compare RVSB & ALVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- ALVR
- Stock Information
- Founded
- RVSB 1923
- ALVR 2013
- Country
- RVSB United States
- ALVR United States
- Employees
- RVSB N/A
- ALVR N/A
- Industry
- RVSB Savings Institutions
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVSB Finance
- ALVR Health Care
- Exchange
- RVSB Nasdaq
- ALVR Nasdaq
- Market Cap
- RVSB 99.6M
- ALVR 87.7M
- IPO Year
- RVSB 1993
- ALVR 2020
- Fundamental
- Price
- RVSB $4.74
- ALVR $0.90
- Analyst Decision
- RVSB
- ALVR Sell
- Analyst Count
- RVSB 0
- ALVR 5
- Target Price
- RVSB N/A
- ALVR $1.00
- AVG Volume (30 Days)
- RVSB 17.9K
- ALVR 155.6K
- Earning Date
- RVSB 10-24-2024
- ALVR 11-04-2024
- Dividend Yield
- RVSB 1.70%
- ALVR N/A
- EPS Growth
- RVSB N/A
- ALVR N/A
- EPS
- RVSB 0.05
- ALVR N/A
- Revenue
- RVSB $46,297,000.00
- ALVR N/A
- Revenue This Year
- RVSB N/A
- ALVR N/A
- Revenue Next Year
- RVSB $12.93
- ALVR N/A
- P/E Ratio
- RVSB $98.52
- ALVR N/A
- Revenue Growth
- RVSB N/A
- ALVR N/A
- 52 Week Low
- RVSB $3.30
- ALVR $0.58
- 52 Week High
- RVSB $6.57
- ALVR $2.49
- Technical
- Relative Strength Index (RSI)
- RVSB 51.94
- ALVR 69.10
- Support Level
- RVSB $4.45
- ALVR $0.74
- Resistance Level
- RVSB $4.72
- ALVR $0.91
- Average True Range (ATR)
- RVSB 0.12
- ALVR 0.06
- MACD
- RVSB -0.00
- ALVR 0.01
- Stochastic Oscillator
- RVSB 61.43
- ALVR 94.50
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.